期刊
JOURNAL OF ONCOLOGY
卷 2022, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2022/3845104
关键词
-
类别
资金
- Shiraz University of Medical Sciences, Shiraz, Iran [24736]
The article emphasizes the significant association between microbiota and cancer, highlighting the role of microbiota in tumor onset, progression, prevention, and treatment. Modulating the composition of microbiota may impact the efficacy of tumor therapy and resistance.
Cancer as a second leading cause of death arises from multifactorial pathology. The association of microbiota and their products with various pathologic conditions including cancer is receiving significant attention over the past few years. Mounting evidence showed that human microbiota is an emerging target in tumor onset, progression, prevention, and even diagnosis. Accordingly, modulating this composition might influence the response to tumor therapy and therapeutic resistance as well. Through this review, one could conceive of complex interaction between the microbiome and cancer in either positive or negative manner by which may hold potential for finding novel preventive and therapeutic strategies against cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据